Fontan Liver Disease: Review of an Emerging Epidemic and Management Options

被引：29
作者：
Bradley E. [1 ,2 ]
Hendrickson B. [1 ,2 ]
Daniels C. [1 ,2 ]
机构：
[1] Department of Internal Medicine, Division of Cardiovascular Medicine, Ohio State University, Columbus, OH
[2] Division Cardiovascular Medicine, Nationwide Children’s Hospital, 700 Children’s Drive, Columbus, 43205, OH
来源：
Current Treatment Options in Cardiovascular Medicine | 2015年 / 17卷 / 11期
关键词：
Cirrhosis; Fontan; Liver disease; Single ventricle;
D O I：
10.1007/s11936-015-0412-z
中图分类号：
学科分类号：
摘要：
Adults with complex congenital heart disease that resulted in a Fontan procedure frequently experience late cardiac failure. Increasingly, liver disease is recognized as an important complication of single-ventricle anatomy and Fontan physiology; however, there is no consensus regarding liver evaluation in this population. Here, we review what is known about liver disease in this unique group and propose screening and prevention measures. We also review controversial treatment areas including assist devices and transplantation, with a review of outcomes in isolated heart and combined heart-liver transplant. © 2015, Springer Science+Business Media New York.
引用
收藏
页数：15
相关论文
共 83 条
[1]  
Fontan F., Baudet E., Surgical repair of tricuspid atresia, Thorax, 26, pp. 240-248, (1971)
[2]  
Fontan F., Et al., Outcome after a “perfect” Fontan operation, Circulation, 81, pp. 1520-1536, (1990)
[3]  
Ghaferi A.A., Hutchins G.M., Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma, J Thorac Cardiovasc Surg, 129, pp. 1348-1352, (2005)
[4]  
Kiesewetter C.H., Et al., Hepatic changes in the failing Fontan circulation, Heart, 93, pp. 579-584, (2007)
[5]  
Friedrich-Rus M., Et al., Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers, J Thorac Cardiovasc Surg, 135, pp. 560-567, (2008)
[6]  
Rychik J., Veldtman G., Rand E., Russo P., Rome J.J., Krok K., Et al., The precarious state of the liver after a Fontan operation: a summary of a multidisciplinary symposium, Pediatr Cardiol, 33, pp. 1001-1012, (2012)
[7]  
Wu F.M., Ukomadu C., Odze R.D., Valente A.M., Mayer J.E., Earing M.G., Liver disease in the patient with Fontan circulation, Congenit Heart Dis, 6, pp. 190-201, (2011)
[8]  
Malinchoc M., Kamath P.S., Gordon F.D., Peine C.J., Rank J., TerBorg P.C.J., A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts, Hepatology, 31, pp. 864-871, (2000)
[9]  
Lemmer J.H., Coran A.G., Behrendt D.M., Heidelberger K.P., Stern A.M., Liver fibrosis (cardiac cirrhosis) five years after modified Fontan operation for tricuspid atresia, J Thorac Cardiovasc Surg, 86, pp. 757-760, (1983)
[10]  
Kendall T., Stedman B., Hacking N., Haw M., Vettukattill J., Salmon A., Et al., Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphologic review, J Clin Pathol, 61, pp. 504-508, (2008)
123456789